|
Post-Intervention Medication Clinical Trials
1 actively recruiting trial across 1 location
New York, New York1 trial
Daratumumab in STK11 Mutated NSCLC
NYU Langone Health
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.